COL3A1 and Myocardial fibrosis: It can be seen that COL1A1, COL1A2, COL3A1, and TGF-β1, which are involved in stimulating the activation of cardiac fibroblasts, are essential in treating of myocardial fibrosis using ZGCD for AF.